(Q24240505)

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Atenolol and chlorthalidone in combination for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Combination of verapamil and beta blockers in systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Effectiveness of Antihypertensive Medications in Office and Ambulatory Settings: A Placebo-Controlled Comparison of Atenolol, Metoprolol, Chlorthalidone, Verapamil, and an Atenolol-Chlorthalidone Combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of renin inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Beta-blockers for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of non-selective beta blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

Blood pressure lowering efficacy of partial agonist beta blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

First-line drugs for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Factorial Antihypertensive Study of an Extended-Release Metoprolol and Hydrochlorothiazide Combination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Nicardipine and propranolol in the treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Atenolol and bendrofluazide in hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Chlorthalidone Alone or in Fixed Combination with Slow-Release Metoprolol in the Management of Arterial Hypertension: A Long-Term Study of 545 Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021

Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007185.PUB2

7 January 2021